Pakpoor, J, Disanto, G, Altmann, D, Pavitt, S, Turner, BP, Marta, M, Juliusson, G, Baker, D, Chataway, J and Schmierer, K. 2015. No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine: Data supplement. [Online]. Neurology: Neuroimmunology & Neuroinflammation. Available from: https://doi.org/10.1212/NXI.0000000000000158
Pakpoor, J, Disanto, G, Altmann, D, Pavitt, S, Turner, BP, Marta, M, Juliusson, G, Baker, D, Chataway, J and Schmierer, K. No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine: Data supplement [Internet]. Neurology: Neuroimmunology & Neuroinflammation; 2015. Available from: https://doi.org/10.1212/NXI.0000000000000158
Pakpoor, J, Disanto, G, Altmann, D, Pavitt, S, Turner, BP, Marta, M, Juliusson, G, Baker, D, Chataway, J and Schmierer, K (2015). No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine: Data supplement. [Data Collection]. Neurology: Neuroimmunology & Neuroinflammation. https://doi.org/10.1212/NXI.0000000000000158
Description
Supplementary data published as part of a comparison of the cancer risk of cladribine and other disease-modifying drugs (DMDs) in trials containing people with relapsing multiple sclerosis (pwRMS).
Keywords
| Data capture method | Experiment |
|---|---|
| Date (Date published in a 3rd party system) | 1 October 2015 |
| Language(s) of written materials | English |
| Data Creators | Pakpoor, J, Disanto, G, Altmann, D, Pavitt, S, Turner, BP, Marta, M, Juliusson, G, Baker, D, Chataway, J and Schmierer, K |
|---|---|
| LSHTM Faculty/Department | Faculty of Epidemiology and Population Health > Dept of Medical Statistics Faculty of Infectious and Tropical Diseases > Dept of Pathogen Molecular Biology |
| Participating Institutions | London School of Hygiene & Tropical Medicine |
| Funders |
|
|---|
| Date Deposited | 20 Oct 2015 10:46 |
|---|---|
| Last Modified | 08 Jul 2021 12:51 |
| Publisher | Neurology: Neuroimmunology & Neuroinflammation |
